Kits Eyecare Statistics

Total Valuation

Kits Eyecare has a market cap or net worth of CAD 276.61 million. The enterprise value is 270.42 million.

Market Cap	276.61M
Enterprise Value	270.42M

Important Dates

The next estimated earnings date is Friday, March 7, 2025.

Earnings Date	Mar 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Kits Eyecare has 31.58 million shares outstanding. The number of shares has increased by 0.35% in one year.

Current Share Class	n/a
Shares Outstanding	31.58M
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+0.72%
Owned by Insiders (%)	25.02%
Owned by Institutions (%)	8.07%
Float	13.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	72.22
PS Ratio	1.89
PB Ratio	5.19
P/TBV Ratio	20.41
P/FCF Ratio	59.09
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 84.11, with an EV/FCF ratio of 57.77.

EV / Earnings	-2,503.85
EV / Sales	1.85
EV / EBITDA	84.11
EV / EBIT	n/a
EV / FCF	57.77

Financial Position

The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.24.

Current Ratio	1.20
Quick Ratio	0.65
Debt / Equity	0.24
Debt / EBITDA	4.03
Debt / FCF	2.77
Interest Coverage	0.44

Financial Efficiency

Return on equity (ROE) is -0.20% and return on invested capital (ROIC) is 0.53%.

Return on Equity (ROE)	-0.20%
Return on Assets (ROA)	0.39%
Return on Invested Capital (ROIC)	0.53%
Return on Capital Employed (ROCE)	0.93%
Revenue Per Employee	1.02M
Profits Per Employee	-755
Employee Count	143
Asset Turnover	1.57
Inventory Turnover	6.01

Taxes

Income Tax	-384,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +49.23% in the last 52 weeks. The beta is 0.32, so Kits Eyecare's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+49.23%
50-Day Moving Average	8.53
200-Day Moving Average	9.00
Relative Strength Index (RSI)	50.82
Average Volume (20 Days)	62,435

Short Selling Information

The latest short interest is 14,456, so 0.05% of the outstanding shares have been sold short.

Short Interest	14,456
Short Previous Month	16,245
Short % of Shares Out	0.05%
Short % of Float	0.18%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kits Eyecare had revenue of CAD 146.17 million and -108,000 in losses. Loss per share was -0.01.

Revenue	146.17M
Gross Profit	48.45M
Operating Income	578,000
Pretax Income	33,000
Net Income	-108,000
EBITDA	2.35M
EBIT	578,000
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 19.15 million in cash and 12.95 million in debt, giving a net cash position of 6.20 million or 0.20 per share.

Cash & Cash Equivalents	19.15M
Total Debt	12.95M
Net Cash	6.20M
Net Cash Per Share	0.20
Equity (Book Value)	53.32M
Book Value Per Share	1.69
Working Capital	6.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.90 million and capital expenditures -2.22 million, giving a free cash flow of 4.68 million.

Operating Cash Flow	6.90M
Capital Expenditures	-2.22M
Free Cash Flow	4.68M
FCF Per Share	0.15

Full Cash Flow Statement

Margins

Gross margin is 33.15%, with operating and profit margins of 0.40% and -0.07%.

Gross Margin	33.15%
Operating Margin	0.40%
Pretax Margin	0.02%
Profit Margin	-0.07%
EBITDA Margin	1.61%
EBIT Margin	0.40%
FCF Margin	3.20%

Dividends & Yields

Kits Eyecare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.35%
Shareholder Yield	-0.35%
Earnings Yield	-0.04%
FCF Yield	1.69%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Kits Eyecare has an Altman Z-Score of 4.45 and a Piotroski F-Score of 5.

Altman Z-Score	4.45
Piotroski F-Score	5